P
Pablo Ivan Pereira Ramos
Researcher at Oswaldo Cruz Foundation
Publications - 45
Citations - 571
Pablo Ivan Pereira Ramos is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 11, co-authored 36 publications receiving 379 citations. Previous affiliations of Pablo Ivan Pereira Ramos include Federal University of Bahia.
Papers
More filters
Journal ArticleDOI
Comparative analysis of the complete genome of KPC-2-producing Klebsiella pneumoniae Kp13 reveals remarkable genome plasticity and a wide repertoire of virulence and resistance mechanisms.
Pablo Ivan Pereira Ramos,Renata Christina Picão,Luiz Gonzaga Paula de Almeida,Nicholas Costa Barroso Lima,Raquel Girardello,Ana Carolina Polano Vivan,Danilo Elias Xavier,Fernando Gomes Barcellos,Marsileni Pelisson,Eliana Carolina Vespero,Claudine Médigue,Ana Tereza Ribeiro de Vasconcelos,Ana Cristina Gales,Marisa Fabiana Nicolás +13 more
TL;DR: The results indicate that the plasticity occurring at many hierarchical levels (from whole genomic segments to individual nucleotide bases) may play a role on the lifestyle of K. pneumoniae Kp13 and underlie the importance of whole-genome sequencing to study bacterial pathogens.
Journal ArticleDOI
Mathematical modeling of COVID-19 in 14.8 million individuals in Bahia, Brazil.
Juliane F. Oliveira,Juliane F. Oliveira,Daniel C. P. Jorge,Rafael V. Veiga,Moreno S. Rodrigues,Matheus F. Torquato,Nívea B. da Silva,Rosemeire L. Fiaccone,Luciana L. Cardim,Felipe A. C. Pereira,Caio P. de Castro,Aureliano S. S. Paiva,Alan A. S. Amad,Ernesto A. B. F. Lima,Diego S. Souza,Suani Tavares Rubim de Pinho,Pablo Ivan Pereira Ramos,Roberto F. S. Andrade,Roberto F. S. Andrade +18 more
TL;DR: In this paper, the authors use mathematical modeling to study the dynamics of COVID-19 in Bahia, a state in northeastern Brazil, considering the influences of asymptomatic/non-detected cases, hospitalizations, and mortality.
Journal ArticleDOI
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets.
Pablo Ivan Pereira Ramos,Darío Fernández Do Porto,Esteban Omar Lanzarotti,Ezequiel Sosa,Germán Federico Burguener,Agustin Maria Pardo,Cecilia C. Klein,Cecilia C. Klein,Cecilia C. Klein,Marie-France Sagot,Marie-France Sagot,Ana Tereza Ribeiro de Vasconcelos,Ana Cristina Gales,Marcelo A. Martí,Adrian Turjanski,Marisa Fabiana Nicolás +15 more
TL;DR: Genomics, transcriptomics, structuromic and metabolic information were integrated in order to prioritize candidate targets and results point towards novel targets for the control of Kp and related bacterial pathogens.
Journal ArticleDOI
Comparative Genomic Analysis of a Clinical Isolate of Klebsiella quasipneumoniae subsp. similipneumoniae, a KPC-2 and OKP-B-6 Beta-Lactamases Producer Harboring Two Drug-Resistance Plasmids from Southeast Brazil.
Marisa Fabiana Nicolás,Pablo Ivan Pereira Ramos,Fabíola Marques de Carvalho,Dhian R A Camargo,Carlene de Fátima Morais Alves,Guilherme Loss de Morais,Luiz Gonzaga Paula de Almeida,Rangel C. Souza,Luciane Prioli Ciapina,Ana Carolina Paulo Vicente,Roney S. Coimbra,Ana Tereza Ribeiro de Vasconcelos +11 more
TL;DR: The first complete genome reported to date of a clinical isolate of this subspecies harboring both class A beta-lactamases KPC-2 and OKP-B-6 from South America is presented and contributes to the description of the characteristics of a novel K. similip pneumoniae strain circulating in South America that currently represent a serious potential risk for nosocomial settings.
Posted ContentDOI
Assessing the nationwide impact of COVID-19 mitigation policies on the transmission rate of SARS-CoV-2 in Brazil
Daniel C. P. Jorge,Moreno S. Rodrigues,Mateus S. Silva,Luciana L. Cardim,Nívea B. da Silva,Ismael Henrique da Silveira,Vivian A. F. Silva,Felipe A. C. Pereira,Suani Tavares Rubim de Pinho,Roberto F. S. Andrade,Pablo Ivan Pereira Ramos,Juliane F. Oliveira +11 more
TL;DR: The results show that population adherence to social distance recommendations plays an important role for the effectiveness of interventions, and represents a major challenge to the control of COVID-19 in low- and middle-income countries.